Argotom-VAX

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameArgotom-VAX
Drug Alias NameHIV DNA vaccine (Immunomic Therapeutics)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLysosome-associated membrane glycoproteins agonists
TargetsLysosome-associated membrane glycoproteins
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenoa BiotecnologiaImmunomic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A